Details of the Drug Reposition

General Information of This Drug (ID: DM2C1YN)

Drug Name	MEGF0444A DM2C1YN

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Metastatic colorectal cancer	DIS18R3K	2B91	Phase 2	[1]
Non-small-cell lung cancer	DIS5Y6R9	2C25.Y	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00909740) A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid Tumors. U.S. National Institutes of Health.